Author:
Kakuda Hirokazu,Kanasaki Keizo,Koya Daisuke,Takekoshi Noboru
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference35 articles.
1. Parker TF 3rd, Blantz R, Hostetter T, Himmelfarb J, Kliger A, Lazarus M, et al. The chronic kidney disease initiative. J Am Soc Nephrol. 2004;15(3):708–16.
2. Makino H, Yasuda Y, Matsuo S. Challenges to chronic kidney disease in Japan: Japan Association of Chronic Kidney Disease Initiative (J-CKDI). Nihon Jinzo Gakkai Shi. 2006;48(8):711–3.
3. Heart-Protection-Study-Collaborative-Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002360(9326):7–22.
4. Tonelli M, Keech A, Shepherd J, Sacks F, Tonkin A, Packard C, et al. Effect of pravastatin in people with diabetes and chronic kidney disease. J Am Soc Nephrol. 2005;16(12):3748–54.
5. Shepherd J, Kastelein JJ, Bittner V, Deedwania P, Breazna A, Dobson S, et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007;2(6):1131–9.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献